| Pharmaceutical Information |
| Drug Name |
Ioxaglate meglumine |
| Drug ID |
BADD_D01187 |
| Description |
Ioxaglic acid is marketed as Hexabrix. This drug is an ionic tri-iodinated benzoate used as a low-osmolality contrast agent during diagnostic imaging procedures. Like other organic iodine compounds, ioxaglic acid blocks x-rays and is opaque in its appearance on x-ray film, improving the visualization of important structures and organs during angiography, arteriography, arthrography, cholangiography, urography, and computed tomography [L1889].
Ioxaglic acid has a low osmolarity and is associated with fewer side effects compared to older contrast agents [L1883]. |
| Indications and Usage |
This medicinal product is for diagnostic use only in adults and children as a low-osmolality medium [L1883], [A7924]. |
| Marketing Status |
approved; investigational |
| ATC Code |
V08AB03 |
| DrugBank ID |
DB09313
|
| KEGG ID |
D04598
|
| MeSH ID |
D007485
|
| PubChem ID |
20055342
|
| TTD Drug ID |
D0X7IT
|
| NDC Product Code |
Not Available |
| UNII |
75JR975T11
|
| Synonyms |
Ioxaglic Acid | Ioxaglate Meglumine | Meglumine, Ioxaglate | Methylglucamine Ioxaglate | Ioxaglate, Methylglucamine | Hexabrix | Ioxaglic Acid, Calcium Salt (2:1) | P-286 (Contrast Media) | P286 (Contrast Media) | Ioxaglate | Ioxaglate Sodium | Ioxaglic Acid Monosodium Salt |
|
| Chemical Information |
| Molecular Formula |
C31H38I6N6O13 |
| CAS Registry Number |
59018-13-2 |
| SMILES |
CC(=O)N(C)C1=C(C(=C(C(=C1I)C(=O)NCC(=O)NC2=C(C(=C(C(=C2I)C(=O)O)I)C(=O)NCCO)I)I)
C(=O)NC)I.CNCC(C(C(C(CO)O)O)O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
